Company Info
Cardiol Therapeutics Inc. is a Canadian biopharmaceutical company established with a focus on developing innovative anti-inflammatory and anti-fibrotic therapies for the treatment of cardiovascular diseases. Founded to address critical unmet medical needs, the company is dedicated to advancing clinical-stage research and delivering cutting-edge treatments aimed at improving heart health. Listed on the Toronto Stock Exchange (TSX) under the ticker symbol CRDL, Cardiol Therapeutics has garnered attention for its scientific rigor and commitment to advancing the field of cardiology. The company's headquarters are strategically located in Canada, serving as the central hub for its research, development, and operational activities. With a mission to harness the power of precision medicine, Cardiol Therapeutics continues to focus on therapeutic innovations designed to improve patient outcomes and establish itself as a leader in cardiovascular care.